Next-generation sequencing-based monitoring of circulating tumor DNA reveals clonotypic heterogeneity in untreated PTCL
Milos D Miljkovic, Christopher Melani, Stefania Pittaluga, Rahul Lakhotia, Nicole Lucas, Allison Jacob, Erik Yusko, Elaine S Jaffe, Wyndham H Wilson, Mark Roschewski, Milos D Miljkovic, Christopher Melani, Stefania Pittaluga, Rahul Lakhotia, Nicole Lucas, Allison Jacob, Erik Yusko, Elaine S Jaffe, Wyndham H Wilson, Mark Roschewski
Abstract
Peripheral T-cell lymphomas (PTCLs) have marked biologic and clinical heterogeneity, which confounds treatment decisions. Advances in circulating tumor DNA (ctDNA) assays using next-generation sequencing (NGS) have improved the detection of molecular relapse and driver mutations in diffuse large B-cell lymphoma and show the potential utility of ctDNA across lymphomas. We investigated NGS-based monitoring of T-cell receptor (TCR) sequences in patients with PTCL undergoing frontline treatment. Of 45 patients, 34 (76%) had tumor-specific clonotypes of the TCRβ or TCRγ genes identified, which included 18 (86%) from baseline tissue and 16 (67%) from baseline serum. Twenty-five (74%) patients had both TCRβ and TCRγ clonotypes, 23 (68%) had more than 1 TCRγ clonotype, and 4 (9%) had multiple TCRβ or TCRγ clonotypes, demonstrating significant intrapatient clonotypic heterogeneity. Among 24 patients with available serial serum samples during treatment, 9 (38%) cleared ctDNA after 2 cycles of therapy, and 11 (46%) had detectable ctDNA at the end of treatment. Patients with detectable ctDNA after therapy showed a trend toward worse survival. Notably, 2 patients with persistently detectable ctDNA after therapy remained in remission with 10 years of follow-up. Clonotypic heterogeneity in tumors and persistence, despite long-term remission, suggests variability in oncological potential. This trial was registered at www.clinicaltrials.gov as #NCT00001337.
© 2021 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
Figures
References
- Vose J, Armitage J, Weisenburger D; International T-Cell Lymphoma Project .International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008;26(25):4124-4130.
- Schmitz N, Trümper L, Ziepert M, et al. . Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group. Blood. 2010;116(18):3418-3425.
- Dunleavy K, Pittaluga S, Shovlin M, et al. . Phase II trial of dose-adjusted EPOCH in untreated systemic anaplastic large cell lymphoma. Haematologica. 2016;101(1):e27-e29.
- Maeda Y, Nishimori H, Yoshida I, et al. . Dose-adjusted EPOCH chemotherapy for untreated peripheral T-cell lymphomas: a multicenter phase II trial of West-JHOG PTCL0707. Blood. 2017;102(12):2097-2103.
- d’Amore F, Relander T, Lauritzsen GF, et al. . Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01. J Clin Oncol. 2012;30(25):3093-3099.
- Rohlfing S, Dietrich S, Witzens-Harig M, et al. . The impact of stem cell transplantation on the natural course of peripheral T-cell lymphoma: a real-world experience. Ann Hematol. 2018;97(7):1241-1250.
- Janikova A, Chloupkova R, Campr V, et al. . First-line therapy for T cell lymphomas: a retrospective population-based analysis of 906 T cell lymphoma patients. Ann Hematol. 2019;98(8):1961-1972.
- Kuzich JA, Hutchison AP, Lim KJC, et al. . Prognostic factors and the impact of frontline therapy in peripheral T-cell lymphoma: 10 years of ‘real-world’ experience from Western Australia. Leuk Lymphoma. 2019; 60(14):3417-3425.
- Roerden M, Walz JS, Müller MR, et al. . The role of autologous stem cell transplantation in peripheral T cell lymphoma: a long-term follow-up single-center experience. J Cancer Res Clin Oncol. 2019;145(10):2595-2604.
- Berg H, Otteson GE, Corley H, et al. . Flow cytometric evaluation of TRBC1 expression in tissue specimens and body fluids is a novel and specific method for assessment of T-cell clonality and diagnosis of T-cell neoplasms. Cytometry B Clin Cytom. 2021;100(3):361–369.
- Shi M, Jevremovic D, Otteson GE, Timm MM, Olteanu H, Horna P.. Single Antibody Detection of T-Cell Receptor αβ Clonality by Flow Cytometry Rapidly Identifies Mature T-Cell Neoplasms and Monotypic Small CD8-Positive Subsets of Uncertain Significance. Cytometry B Clin Cytom. 2020; 98(1):99-107.
- Schützinger C, Esterbauer H, Hron G, et al. . Prognostic value of T-cell receptor gamma rearrangement in peripheral blood or bone marrow of patients with peripheral T-cell lymphomas. Leuk Lymphoma. 2008;49(2):237-246.
- de Masson A, O’Malley JT, Elco CP, et al. . High-throughput sequencing of the T cell receptor β gene identifies aggressive early-stage mycosis fungoides. Sci Transl Med. 2018;10(440):eaar5894.
- Rea B, Haun P, Emerson R, et al. . Role of high-throughput sequencing in the diagnosis of cutaneous T-cell lymphoma. J Clin Pathol. 2018; 71(9):814-820.
- Roschewski M, Dunleavy K, Pittaluga S, et al. . Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study. Lancet Oncol. 2015;16(5):541-549.
- Kurtz DM, Green MR, Bratman SV, et al. . Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing. Blood. 2015;125(24):3679-3687.
- Scherer F, Kurtz DM, Newman AM, et al. . Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA. Sci Transl Med. 2016;8(364):364ra155.
- Kurtz DM, Scherer F, Jin MC, et al. . Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma. J Clin Oncol. 2018;36(28):2845-2853.
- Kurtz DM, Esfahani MS, Scherer F, et al. . Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction. Cell. 2019; 178(3):699-713.e19.
- Swerdlow SH, Campo E, Pileri SA, et al. . The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016; 127(20):2375-2390.
- Wilson WH, Grossbard ML, Pittaluga S, et al. . Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy. Blood. 2002;99(8):2685-2693.
- Cheson BD, Pfistner B, Juweid ME, et al. ; International Harmonization Project on Lymphoma . Revised response criteria for malignant lymphoma. J Clin Oncol. 2007;25(5):579-586.
- Juweid ME, Wiseman GA, Vose JM, et al. . Response assessment of aggressive non-Hodgkin’s lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography. J Clin Oncol. 2005;23(21):4652-4661.
- Weng W-K, Armstrong R, Arai S, Desmarais C, Hoppe R, Kim YH.. Minimal Residual Disease Monitoring with High-Throughput Sequencing of T Cell Receptors in Cutaneous T Cell Lymphoma. Sci Transl Med. 2013;5(214):214ra171.
- Carlson CS, Emerson RO, Sherwood AM, et al. . Using synthetic templates to design an unbiased multiplex PCR assay. Nat Commun. 2013;4:2680.
- Wu D, Sherwood A, Fromm JR, et al. . High-Throughput Sequencing Detects Minimal Residual Disease in Acute T Lymphoblastic Leukemia. Sci Transl Med. 2012;4(134):134ra163.
- El-Asmar J, Reljic T, Ayala E, et al. . Efficacy of High-Dose Therapy and Autologous Hematopoietic Cell Transplantation in Peripheral T Cell Lymphomas as Front-Line Consolidation or in the Relapsed/Refractory Setting: A Systematic Review/Meta-Analysis. Biol Blood Marrow Transplant. 2016;22(5):802-814.
- Fossard G, Broussais F, Coelho I, et al. . Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers. Ann Oncol. 2018;29(3):715-723.
- Kanakry JA, Kasamon YL, Gocke CD, et al. . Outcomes of related donor HLA-identical or HLA-haploidentical allogeneic blood or marrow transplantation for peripheral T cell lymphoma. Biol Blood Marrow Transplant. 2013;19(4):602-606.
- Blüthmann H, Kisielow P, Uematsu Y, et al. . T-cell-specific deletion of T-cell receptor transgenes allows functional rearrangement of endogenous alpha- and beta-genes. Nature. 1988;334(6178):156-159.
- Yassai MB, Naumov YN, Naumova EN, Gorski J.. A clonotype nomenclature for T cell receptors. Immunogenetics. 2009;61(7):493-502.
- Kanavaros P, Farcet JP, Gaulard P, et al. . Recombinative events of the T cell antigen receptor delta gene in peripheral T cell lymphomas. J Clin Invest. 1991;87(2):666-672.
- Gong Q, Wang C, Zhang W, et al. . Assessment of T-cell receptor repertoire and clonal expansion in peripheral T-cell lymphoma using RNA-seq data. Sci Rep. 2017;7(1):11301.
- Hamrouni A, Fogh H, Zak Z, Ødum N, Gniadecki R.. Clonotypic diversity of the T-cell receptor corroborates the immature precursor origin of cutaneous T-cell lymphoma. Clin Cancer Res. 2019;25(10):3104-3114.
- Iyer A, Hennessey D, O’Keefe S, et al. . Clonotypic heterogeneity in cutaneous T-cell lymphoma (mycosis fungoides) revealed by comprehensive whole-exome sequencing. Blood Adv. 2019;3(7):1175-1184.
- Farmanbar A, Kneller R, Firouzi S.. RNA sequencing identifies clonal structure of T-cell repertoires in patients with adult T-cell leukemia/lymphoma. NPJ Genom Med. 2019;4(1):10.
- Rauch DA, Conlon KC, Janakiram M, et al. . Rapid progression of adult T-cell leukemia/lymphoma as tumor infiltrating Treg cells after PD-1 blockade. Blood. 2019; 134(17):1406-1414.
- Ottolini B, Nawaz N, Trethewey CS, et al. . Multiple mutations at exon 2 of RHOA detected in plasma from patients with peripheral T-cell lymphoma. Blood Adv. 2020;4(11):2392-2403.
- Schatz JH, Horwitz SM, Teruya-Feldstein J, et al. . Targeted mutational profiling of peripheral T-cell lymphoma not otherwise specified highlights new mechanisms in a heterogeneous pathogenesis. Leukemia. 2015;29(1):237-241.
- Watatani Y, Sato Y, Miyoshi H, et al. . Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling. Leukemia. 2019;33(12):2867-2883.
- Theodorou I, Raphaël M, Bigorgne C, et al. . Recombination pattern of the TCR gamma locus in human peripheral T-cell lymphomas. J Pathol. 1994; 174(4):233-242.
- Tan BT, Warnke RA, Arber DA.. The frequency of B- and T-cell gene rearrangements and epstein-barr virus in T-cell lymphomas: a comparison between angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified with and without associated B-cell proliferations. J Mol Diagn. 2006;8(4):466-475, quiz 527.
Source: PubMed